New hope for a syphilis vaccine
Researchers have identified exterior proteins on the bacteria that could serve as vaccine targets for syphilis.
List view / Grid view
Researchers have identified exterior proteins on the bacteria that could serve as vaccine targets for syphilis.
Results from a pivotal trial of a new HIV therapy, show that PRO 140 is an effective, long-acting therapeutic for previously treated HIV-1 infected patients...
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies...
Nanoparticles could offer a new way to help eradicate the disease worldwide...
By engineering a special molecule to track certain immune cells in the body, scientists have invented a litmus test for the effectiveness of a newly devised cancer therapy...
Researchers synthesized self-assembling peptide amphile nanofibers that targeted areas of plaque and could be delivered by intravenous injection...
Fast Track program is designed to facilitate development and expedite review of therapies and vaccines to address unmet health needs...
A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States...
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking...
Researchers have developed a vaccine for one of the most dangerous types of synthetic cathinones...
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the NIAID...
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States...
Medical researchers point to a promising route for designing an effective vaccine for the respiratory syncytial virus...
Tenofovir disoproxil fumarate (TDF) does not significantly reduce mother-to-child transmission of hepatitis B virus when taken during pregnancy and after delivery.